Mutations decreasing complexity are more frequent than mutations increasing it. حسب Pascal F. Hagolani (10189866)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

List of rare PGx variants. حسب Ewa Goljan (3463487)

Linear regressions of consumer stable carbon and nitrogen isotope values and collection date. حسب Nathan D. McTigue (10706460)

الموضوعات:

Mathematical treatments applied to data to correct stable isotope values for lipid content. حسب Nathan D. McTigue (10706460)

الموضوعات:

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. حسب Simon K. Schnyder (16632244)

MC depletion decreases aneurysmal growth after dissections in ApoE-RMB mice. حسب Alexia Loste (17592915)

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments حسب Steven R. Shuken (14500192)

"…The tremendous false discovery rate (FDR) benefit of correction was confirmed in a range of different contexts. No correction method can guarantee a low FDP in a single experiment, but the probability of a high FDP is small when a high number and proportion of corrected <i>p</i>-values are significant. …"

Proportion of genotype calls with both alleles correct (2), one allele incorrect (1) and two alleles incorrect (0) at different sequencing coverages. حسب Harrison J. Lamb (11722247)

Survival probability of cercariae in 0.38 ppt, 1.9 ppt, 3.8 ppt, and 5.7 ppt salinity treatments over a 24-hour period. حسب Ao Yu (1348512)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). حسب Willem Kaijser (12872371)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. حسب Peiqi Yin (6533747)

Mean values of “I feel bored” item. حسب Ezel Üsten (16548547)

Bacterial abundance in L2 larvae collected from larval flasks inoculated with decreasing quantities of glycerol stock (bacteria source). حسب Margaret V. Becker (21387776)

Refinement of scrambles, with no USM decreases. حسب Jedediah M. Singer (10331212)

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)